New MS Treatment Shows Promise in Trial

[ad_1]

By Amy Norton
HealthDay Reporter

THURSDAY, Aug. 25, 2022 (HealthDay News) — An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found.

The drug, called ublituximab, beat a standard oral medication for MS in reducing patients’ relapses — periods of new or worsening symptoms. It also proved better at preventing areas of inflammatory damage in the brain.

Ublituximab is not yet approved for treating MS; the U.S. Food and Drug Administration is reviewing the trial data and is expected to make a decision by the year’s end, according to drugmaker TG Therapeutics.

If approved, ublituximab would be the latest in a newer group of MS therapies called anti-CD20 monoclonal antibodies: lab-engineered antibodies that target specific immune system cells that drive the MS process.

The new findings offer more proof that the approach benefits patients, according to an expert who was not involved in the trial.

“Is this revolutionary? No. But it’s further confirmation of a clinical benefit from targeting this population of cells in the blood,” said Dr. Lauren Krupp, who directs NYU Langone’s Multiple Sclerosis Comprehensive Care Center in New York City.

MS is a neurological disorder that usually arises between the ages of 20 and 40. It’s caused by a misguided immune system attack on the body’s own myelin — the protective sheath around nerve fibers in the spine and brain. Depending on where the damage occurs, symptoms include vision problems, muscle weakness, numbness, and difficulty with balance and coordination.

Most people with MS have the relapsing-remitting form, where symptoms flare for a period, then ease. Over time, the disease becomes more steadily progressive.

Immune system cells called B cells seem to play an especially key role in driving MS. So recent years have seen the development of monoclonal antibodies that deplete the blood of B cells. One, called ocrelizumab (Ocrevus), was approved in the United States in 2017. A second — ofatumumab (Kesimpta) — followed in 2020.

Both antibodies deplete B cells by targeting a protein on the cells called CD20. Ublituximab has the same target, but it’s engineered to be more potent at killing B cells, said Dr. Lawrence Steinman, lead researcher on the new trial.

The trial did not compare ublituximab against either existing anti-CD20 antibody, stressed Steinman, a professor of neurology at Stanford University. So it’s not known whether it’s any more or less effective.

But a potential advantage of the new antibody, Steinman said, is that it can be administered rapidly.

Both Ocrevus and ublituximab require patients to go to a medical facility for infusions every six months. But an Ocrevus infusion takes about three hours, while ublituximab can be given in one hour.

Kesimpta, meanwhile, avoids infusions altogether. It’s taken at home once a month, using an auto-injector.

“There are different solutions for different people,” Steinman said. “I think it’s always good to have options.”

The findings, published Aug. 25 in the New England Journal of Medicine , are based on more than 1,000 patients with MS, mostly the relapsing-remitting form. A small percentage had secondary progressive MS, a second phase of the disease that follows the relapsing-remitting years.

About half were randomly assigned to ublituximab infusions, while the other half took the oral medication Aubagio (teriflunomide).

Over 96 weeks, ublituximab patients were half as likely to have a relapse — with an average annual rate of just under 0.1, versus almost 0.2 among Aubagio patients. And on MRI scans, they showed fewer areas of inflammation in the brain.

B cells are responsible for churning out infection-fighting antibodies. So a main safety concern with B-cell depletion is that it can leave people more vulnerable to infection. That was the case in this trial: 5% of ublituximab patients developed a serious infection, including pneumonia, versus 3% of Aubagio patients.

There are many drugs approved to treat MS. But Krupp said some recent studies are showing that patients fare better long term when they get “high-efficacy” medications — which include anti-CD20 antibodies — versus older drugs with more-moderate effects.

To Steinman, earlier is better when it comes to starting high-efficacy treatment.

“My philosophy is, if insurance will cover it, knock the disease down hard and fast,” he said.

That brings up the real-world issue of cost: CD20 monoclonal antibodies are expensive; the current list price for Ocrevus is about $68,000 per year, according to drugmaker Genentech.

So often, both Krupp and Steinman said, medication decisions depend on which ones are covered by a patient’s insurance plan.

More information

The National Multiple Sclerosis Society has more on treating MS.

SOURCES: Lawrence Steinman, MD, director and professor, neurology and neurological sciences, and pediatrics, Beckman Center for Molecular Medicine, Stanford University, Stanford, Calif.; Lauren Krupp, MD, director, NYU Langone Multiple Sclerosis Comprehensive Care Center, and professor, pediatric neuropsychiatry, NYU Grossman School of Medicine, New York City; New England Journal of Medicine, Aug. 25, 2022

[ad_2]

Source link

139 thoughts on “New MS Treatment Shows Promise in Trial

  • July 28, 2024 at 12:53 pm
    Permalink

    Did you understand these truths on CBD OIL and Full Spectrum CBD Hemp Oil? Cannabinoids are isolated from hemp utilizing supercritical CO2 extraction. Thanks to modern-day innovation, the resulting service is clean, devoid of unnecessary waxes and heavy metals, naturally present in the plant, and the sucked liquid has a common, oily consistency. CBD oil contains cannabidiol as a base ingredient and may consist of just trace quantities of tetrahydroxycannabidiol (THC). It is recommended by physicians and pharmacists as an antioxidant and substance that obstructs the action of proinflammatory cytokines (proteins), e.g. in Crohn’s illness or ulcerative intestine. RSO oil has a low CBD material, while high THC. Obviously, the essential task of RSO is to cause a psychedelic result, although it can also stimulate “ill” brain structures. It is worth understanding that supplementation of this type is mostly utilized by individuals to whom standard treatment does not bring relief in illness. The synergistic (enhancing) action of CBD and THC relative to each other is utilized here. When utilized separately, both cannabinoids can do much more together than. In addition, they jointly promote the department of inactive nerve cells, nurture the fatty envelope of the nerves, and prevent myelin inflammation that causes loss of function in some autoimmune illness. There are also stories where marijuana in its natural form softened spasticity, decreased the frequency of seizures and convulsions, and reduced unpleasant scrapie in Parkinson’s illness. This is where the idea of receiving RSO, meant only for chronically ill individuals, stemmed . Both cannabis oil type CBD and RSO likewise contain other cannabinoids, such as cannabichromene (CBC) and cannabigerol (CBG). The secret is not, nevertheless, that CBD often has a composition expanded to include flavones, flavonoids, terpenes, terpenoids, amino acids and omega acids. The distinction is mainly due to intentions assisting humankind to utilize one or the other item. CBD medical cannabis oil is a rather helpful mix of cannabinoids, developed to protect versus 21st century illness. It’s best to use all of these substances together, as nature developed them and enclosed in marijuana inflorescences. Oil of cannabis in a kind of hobby APR contains small quantities of CBD, balanced by the presence of THC. – Modern scientific research shows that CBD + THC cope with serious autoimmune illness, while CBC or CBG show very little activity in the existence of both compounds, simply like terpenes, flavones or flavonoids, therefore their content in the option seems to be unnecessary. In addition, the marijuana pressure from which THC and CBD are derived include negligible amounts of other cannabinoids. Cannabis oil has currently marked a new age in which man stopped to fear what is unidentified, and started to rediscover what our forefathers had already noticed and use the significant potential, initially glance, a little strange relationships, associated primarily with pathology. Medical marijuana, contrary to its name, does not indicate fermented female inflorescences and leaves containing psychedelic compounds coiled in so-called “Joints”, however an advantageous oil without psychoactive THC. A standard person, after taking doses of medical cannabis and achieving the proper state of cannabinoids in the blood, can enjoy increased resistance, minimized vulnerability to cancer, delayed aging and reduced threat of stroke or heart attack. CBD oil consists of cannabidiol as a base component and might consist of just trace quantities of tetrahydroxycannabidiol (THC). RSO oil has a low CBD content, while high THC. Both cannabis oil type CBD and RSO also contain other cannabinoids, such as cannabichromene (CBC) and cannabigerol (CBG). CBD medical marijuana oil is a rather useful mix of cannabinoids, developed to protect versus 21st century disease. Oil of marijuana in a kind of pastime APR consists of small quantities of CBD, stabilized by the existence of THC.

  • August 2, 2024 at 1:37 am
    Permalink

    Fantastic post however , I was wanting to know if you could write a litte more on this topic? I’d be very thankful if you could elaborate a little bit further. Appreciate it!

  • August 24, 2024 at 1:27 pm
    Permalink

    Trong thời kỳ biến động mạnh mẽ của giá cả trên thị trường quốc tế, các công cụ phái sinh như hợp đồng tương lai và quyền chọn trở thành những biện pháp hiệu quả giúp doanh nghiệp và nhà đầu tư bảo vệ mình khỏi rủi ro về giá. SACT là một trong những công ty hàng đầu cung cấp các giải pháp phái sinh này, giúp khách hàng có thể kiểm soát tốt hơn biến động giá và đảm bảo lợi nhuận trong dài hạn. Với sự hỗ trợ từ đội ngũ chuyên gia của SACT, các doanh nghiệp có thể chủ động quản lý nguồn cung ứng và bảo vệ lợi nhuận của mình trước những biến động khó lường.

  • September 2, 2024 at 5:54 pm
    Permalink

    LMCHING is a trusted e-commerce site that offers an extensive selection of high-end cosmetics from Europe and Korea. Their range of European brands comprises Helena Rubinstein, La Prairie, La Mer, and SkinCeuticals, while their Korean offerings include brands like Medi Peel, The History of Whoo, Sulwhasoo, and REJURAN. Every product sold on LMCHING is genuine and competitively priced. Furthermore, LMCHING is noted for its impressive selection of fragrances from Maison Alhambra and Lattafa, solidifying its reputation among beauty aficionados.

  • September 15, 2024 at 5:16 pm
    Permalink

    LMCHING stands out as a leading e-commerce site featuring a vast array of high-end European beauty products from names like La Mer. They also specialize in Korean skincare, showcasing leading brands like Medi Peel. Every product on LMCHING is ensured to be real, and their prices are affordable. Moreover, LMCHING is famous for its wide range of perfumes from Lattafa, which makes it a preferred destination for beauty lovers.

  • September 22, 2024 at 6:19 pm
    Permalink

    There are some interesting time limits on this article however I don’t know if I see all of them center to heart. There may be some validity but I’ll take hold opinion until I look into it further. Good article , thanks and we would like extra! Added to FeedBurner as effectively

  • October 25, 2024 at 7:17 am
    Permalink

    What are the 3 criteria to help choose a sim suitable for 1977? According to feng shui experts, when choosing a sim card for people born in 1977 (Fire element), three criteria should be considered: Five elements are compatible (choose numbers belonging to the Wood and Fire elements), and the meaning of each number (for example 6). is Loc, 8 is Phat), and the overall harmony of the number sequence (sum of nodes, arrangement). Learn in detail about the 3 criteria for choosing a sim suitable for 1977 and how to apply.

  • October 30, 2024 at 11:48 pm
    Permalink

    F*ckin’ remarkable issues here. I’m very satisfied to see your article. Thanks so much and i’m looking forward to contact you. Will you kindly drop me a e-mail?

  • November 6, 2024 at 3:18 pm
    Permalink

    LMCHING has unveiled its green shipping program, designed to
    offset the carbon footprint of La Mer orders through
    certified sustainability initiatives in the two European regions.
    This focus to eco-friendliness appeals to environmentally aware
    consumers who are seeking ways to support eco-friendly actions while indulging in exclusive skincare solutions.

    In parallel with its environmental efforts, LMCHING boasts a strong reputation for speedy fulfillment, solidifying its place
    as a reliable supplier of La Mer goods in the United Kingdom and French regions.
    With products delivered within just three business days, LMCHING
    regularly outperforms competitors, ensuring that customers receive their purchases
    on time and with ease.

    This speedy fulfillment elevates the end-to-end experience,
    perfectly complementing LMCHING’s commitment to ensuring original La Mer items at market-friendly prices.
    Customers experience real items while knowing they are supporting a company that prioritizes the environment.

    The glowing reviews from countless buyers across both regions highlights
    LMCHING’s dedication to quality and service. Many customers have
    appreciated the streamlined customer journey and the integrity of the products, affirming
    LMCHING’s standing as a market leader in the beauty industry.

    In summary, LMCHING’s environmentally responsible shipping approach, paired with its fast shipping and devotion to authenticity,
    positions the company as a trailblazer in environmentally conscious cosmetics distribution in the two European regions.
    By making central environmental responsibility and shopper experience, LMCHING
    revolutionizes what it means to invest in exclusive skincare.

    La Mer’s overnight treatments target the renewal of the epidermis while users sleep, capitalizing on the body’s
    inherent repair mechanisms. Central to these skincare
    solutions is the brand’s iconic Miracle Broth,
    which is rich in nutrients and helps to promote dermal repair.
    This essential formula operates throughout the night to moisturize, calm, and enhance the skin’s protective layer, producing a more radiant complexion by sunrise.

    La Mer offers several night treatments, including
    the Intensive Revitalizing Mask and the restorative serum. These solutions combat various
    concerns including skin dryness, fatigue, and wrinkles. The evening care products focus on sink into the dermis, offering deep care and
    assisting in rejuvenation {caused by environmental stressors|from
    external factors|triggered by pollution

  • November 16, 2024 at 8:56 pm
    Permalink

    I’m truly enjoying the design and layout of your website. It’s a very easy on the eyes which makes it much more enjoyable for me to come here and visit more often. Did you hire out a designer to create your theme? Outstanding work!

Leave a Reply

Your email address will not be published.